StockWatch
·

BLISS GVS PHARMA LTD. Q1 FY26 Results

BLISSGVSQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue207.474.8%
Total Income242.9215.7%
Expenditure179.813.6%
PBT63.11169.2%
Net Profit44.36166.4%
OPM19.92%9.27pp
NPM18.26%10.33pp
EPS4.08177.6%
View full financials

Informational and educational content only. Not investment advice.